TYRA compared with PBLS: revenue, margins and what each company keeps, and the suppliers and customers both name

TYRATyra Biosciences, Inc.

Mkt capRevenueRevenue

PBLSParabilis Medicines, Inc.

Mkt capRevenueRevenue

Compare

TYRATyra Biosciences, Inc.

PBLSParabilis Medicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TYRA 0

None

Shared 0

No disclosed counterparties: TYRA.

Only PBLS 2

REGNRegeneron Pharmaceuticalscustomer

—Alcamiunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

TYRATyra Biosciences, Inc.

21.38▲+1.48%· post 21.35· delayed

Mkt cap$1.3BRevenue—

PBLSParabilis Medicines, Inc.

27.29▼−3.63%· post 27.14· delayed

After hoursNov 2 '26delayed

Mkt cap$818.7MRevenue$148,000Q2 FY26

Compare

After hoursNov 2 '26delayed

TYRATyra Biosciences, Inc.

PBLSParabilis Medicines, Inc.

21.38▲+1.48%post 21.35delayed

Price

27.29▼−3.63%post 27.14delayed

$1.3B

Mkt cap

$818.7M

—

Revenue

$148,000Q2 FY26

TYRA21.38▲+1.48%vsPBLS27.29▼−3.63%After hoursNov 2 '26delayed